# AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer

> **NCT01287130** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 10 (actual)

## Conditions studied

- Colonic Neoplasms
- Cancer of the Colon
- Colon Cancer
- Colon Neoplasms
- Colonic Cancer

## Interventions

- **DRUG:** Cetuximab
- **DRUG:** AZD6244

## Key facts

- **NCT ID:** NCT01287130
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01-07
- **Primary completion:** 2013-08-27
- **Final completion:** 2013-08-27
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01287130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01287130, "AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01287130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*